Jump to content

Serostim

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by GünniX (talk | contribs) at 13:19, 10 April 2020 (Reflist). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Serostim (recombinant DNA somatropin) is Serono's brand name prescription drug form of synthetic growth hormone, marketed for HIV-associated wasting.[1]

In December 2007, the U.S. District Court of Massachusetts - in a class-action lawsuit that involved Merck Serono and Serostim - fined Serono a total of $704 million in criminal and civil liabilities for enacting "illegal schemes to promote, market and sell its drug."[2]

References

  1. ^ "Serostim® (somatropin) For Injection | Website For Patients". Serostim.
  2. ^ "SERONO TO PAY $704 MILLION FOR THE ILLEGAL MARKETING OF AIDS DRUG". Department of Justice. 17 October 2005. Retrieved 23 June 2018.


Stub icon

This hormonal preparation article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Serostim&oldid=950148014"